Approval · Notice of Compliance 1166 · 2000
PEPCID PLUS: Notice of Compliance 1166
Issued June 12, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1166
- Date
- June 12, 2000
- Company
- Merck Frosst Canada & Cie, Merck Frosst Canada & Co.Kirkland, Quebec, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Combination: histamine h2-receptor antagonist and antacid
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PEPCID PLUS | 02242357 | — |
Medicinal ingredients
- CALCIUM CARBONATE 800 MG per TAB
- FAMOTIDINE 10 MG per TAB
- MAGNESIUM HYDROXIDE 165 MG per TAB